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Endothelin-1 stimulates the Na/H and Na/HCO3 transporters in
rabbit renal cortex. Endothelin-I (ET-I) is the most potent endogenous
vasoconstrictor identified to date, raising the strong possibility of its
involvement in the pathogenesis of systemic hypertension. Whether
ET-l exerts a direct stimulating effect on sodium reabsorption in the
renal proximal convoluted tubule, the dominant locus of sodium reab-
sorption in the nephron, is currently unknown. Such an effect would
suggest yet another mechanism by which ET-l might mediate systemic
hypertension. In studies on membrane vesicles prepared from rabbit
renal cortex, we show that ET-l (10-8 to 10_ti M) exerts dose-
dependent stimulation of the apical Na/H exchanger and the baso-
lateral Na/HCO3 cotransporter; preincubation of vesicles with 10—10
s ET- 1 for five minutes enhanced the activity of each transporter by
approximately 25%. This stimulation reflected an increase in the V,,,
of each transporter but no change in the Km for sodium. The stimulatory
effect of ET-l was blocked in the presence of an ET-l antiserum.
Moreover, the stimulation of the apical Na/H exchanger and the
basolateral Na/HCO3 cotransporter by ET-l displayed specificity as
indicated by the lack of effects on the activities of the apical Na-
glucose transporter and the basolateral Na-succinate transporter. The
data implicate ET-l as a novel, direct and specific modulator of sodium
reabsorption in the proximal tubule. As such, ET-l might be a direct
determinant of extracellular fluid volume under normal and pathophys-
iologic circumstances, including hypertensive disorders.
The recent discovery of the endothelin family of peptides [1]
has triggered an explosion of investigation towards defining
their biologic roles. Endothelin-l (ET-l), a 21-amino acid pep-
tide, is the most potent endogenous vasoconstrictor identified
to date; consequently, it has been implicated in the regulation of
regional and systemic hemodynamics in health and disease [2,
3]. Enhanced resistance of systemic and regional vessels is the
pathophysiologic hallmark of established hypertension. Al-
though it is currently believed that ET-1 exerts its effects
primarily as an autocrine or paracrine factor, increased levels of
ET-l have been identified in some [4, 5], but not all [6], studies
in patients with essential hypertension. A provocative report on
two patients with malignant hemangioendothelioma linked sys-
temic hypertension with production of ET- 1 by the tumor [7].
Moreover, heightened reactivity to ET-l in large and small
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vessels of various animal models of hypertension has been
observed [8—Il].
A large body of evidence indicates that retention of sodium
by the kidney is of central importance in the pathogenesis of
hypertensive states [12]. In this regard, infusion of pharmaco-
logic doses of exogenous ET- 1 induces marked renal vasocon-
striction and hypofiltration [2, 3, 13]. Whether ET-1 enhances
directly the reabsorption of sodium in the renal proximal
convoluted tubule, the major site of sodium reabsorption in the
nephron, remains unknown. Yet, other vasoactive substances
with established relevance to the pathophysiology of hyperten-
sion, including angiotensin II and norepinephrine, are known to
be powerful direct modulators of both glomerular hemodynam-
ics and proximal tubular sodium reabsorption [14—171. Indeed,
several lines of evidence point to a physiologic role for ET- 1 in
the proximal nephron. First, endothelin-like immunoreactivity
has been identified in brush border membranes from early
proximal tubular segments of rats [18]. Second, radiolabeled
ET-1 binds to proximal tubules, although less prominently than
to glomeruli, inner medulla and vasa recta bundles [19]. Finally,
studies on the effects of exogenous ET-1 on renal sodium
handling in vivo have yielded conflicting results due, at least in
part, to confounding changes in renal hemodynamics. How-
ever, infusion of an ET-1 antiserum in rats maintained on a
low-sodium diet led to a significant increase in the fractional
excretion of sodium in the absence of changes in whole-kidney
hemodynamics [20]. We have therefore examined the effect of
ET-1 on the apical Na/H exchanger and the basolateral
NaIHCO3 cotransporter, the major entry and exit steps for
the vectorial transport of sodium across the proximal tubule
cell.
Methods
Preparation of membrane vesicles
Brush border membrane vesicles (BBMV) and basolateral
membrane vesicles (BLMV) were prepared from rabbit renal
cortex by modifications [21] of a Mg k-aggregation method [22]
and a Percoll gradient method [23], respectively. Briefly, male
New Zealand white rabbits, weighing 2.3 to 2.7 kg, were
sacrificed using sodium pentobarbital and their kidneys were
removed. The cortex was separated from the medulla and
minced using a razor blade. Minced cortex from two kidneys
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was added with 200 m sucrose, 25 mrs'i K gluconate, 2 mM
EDTA, 10 mi N-2-hydroxyethylpiperazine-N'-2-ethanesulfon-
ic acid (HEPES), pH 7.6 with tetramethylammonium hydroxide
(TMAOH) so that the final volume was 70 ml. This suspension
was homogenized with a teflon pestle-glass homogenizer (2,000
rpm, 10 strokes with a loose pestle, 30 strokes with a tight
pestle) and then centrifuged at 17,500 rpm (37,000 g, Sorvall
SS-34 rotor) for 30 minutes. When making BLMV, a prelimi-
nary centrifugation of the homogenate at 3,000 rpm for 10
minutes was done and the pellet was discarded. The 17,500 rpm
precipitate was used to make BBMV or BLMV as outlined
below.
BBMV. The pellet was resuspended in 25 m'vi K gluconate, 2
m ethylene glycol-bis(/3-aminoethyl ether)-N ,N ,N ',N '-tet-
raacetic acid (EGTA), 10 ms'i HEPES pH 7.6 (with KOH) and
homogenized with one to three strokes of a teflon pestle-glass
homogenizer. Subsequently, I M MnCl2 or MnSO4 (0.7 ml) was
added and the homogenate diluted to 70 ml with resuspension
medium. After stirring on ice for 20 minutes, the solution was
centrifuged at 4,000 rpm for 10 minutes and the pellet was
discarded. The supernatant was again centrifuged at 17,000 to
19,000 rpm for 30 minutes and the pellet was purified BBMV. In
BBMV, average enrichment in specific activity (final pellet!
initial homogenate) of maltase, a brush-border membrane
marker, was 9.2 0.4 (mean sEM), and of Na!K ATPase,
a basolateral membrane marker, 0.9 0.1 (N 15). Protein
concentration of BBMV ranged from 60 to 100 mg/mI (N = 15).
BLMV. The lower brown part of the 17,500 rpm pellet was
discarded and the upper part was suspended in homogenizing
solution. This solution was centrifuged at 18,500 rpm for 30
minutes. The upper part of this pellet (crude membranes) was
resuspended in homogenizing medium. Percoll mixtures were
prepared as follows: four tubes per two rabbits, each tube
contained 4 g Percoll, 19 g homogenizing medium and 2 ml
crude membrane suspension. The Percoll solutions were cen-
trifuged at 19,000 rpm (Beckman, Ti 50.2 rotor) for 40 minutes
to form a gradient. The distinct upper band in the upper half of
the gradient was aspirated and pooled. These pooled fractions
were centrifuged at 45,000 rpm for 60 minutes to remove
Percoll. Purified BLMV were found above a hard Percoll pellet.
In BLMV, Na!K ATPase enrichment averaged 12.5 1.0
and that of maltase 0.9 0.1 (N = 15). Protein concentration of
BLMV ranged from 60 to 100 mg/mI (N = 15).
Measurement of Nat'H exchange activity in BBMV
BBMV were equilibrated in a medium containing 150 mM
KCI, 1 mrt EGTA, I mri Mg gluconate, 50 mM MES, 25 mM
HEPES, titrated to pH 6,5 with KOH. The suspension of
BBMV was left at room temperature for 30 minutes. ET-l (108
to 10 M; Cal Biochem, San Diego, California, USA) was
added to vesicles either 5 or 15 minutes before the transport
assay, depending on the series of experiments. To study trans-
port, 10 1,d of BBMV suspension were added to 50 p1 of
transport medium containing 150 mrvi KCI, 1 mM EGTA, 1 mM
Mg gluconate, 25 mM mannitol, 50 mtvi HEPES, 1 mrvi 22Na
gluconate, valinomycin (10 p1 of ethanol stock solution, 2.5
mg/mI, per ml of transport medium), pH 8.0, in the presence or
absence of 1 mivi amiloride. 22Na was measured by a rapid
filtration technique [211.
Measurement of Na
-dependent D-glucose transport in
BBMV
BBMV were equilibrated in a medium containing 100 mM K
gluconate, 1 mM EGTA, 1 m Mg gluconate, 100 mrvi mannitol,
50 mM HEPES, pH 7.5 (titrated with KOH). To study trans-
port, 10 pA of vesicle suspension were added to 50 p1 of
transport medium containing 100 mM NaC1 or KCI, 1 mM
EGTA, 1 m Mg gluconate, 100 m'vi mannitol, 50 mM HEPES,
pH 7.5 and 0.05 mi D-[3H1 glucose. Correction for passive
uptake was made by subtracting the uptake in KC1 medium
from the uptake in NaCI medium.
Measurement of Na/HCO3 cotransporter activity in BLMV
BLMV were equilibrated in a medium containing 150 mM
tetramethylammonium (TMA) gluconate, 1 mM EGTA, 1 mM
Mg gluconate, 50 mM MES, 10 mi'i HEPES, titrated to pH 7.0
with TMAOH. The suspension of BLMV was left at room
temperature for 30 minutes. ET-l (10—8 to lO NI) was added
to vesicles either 5 or 15 minutes before the transport assay,
depending on the series of experiments. To study transport, 10
p1 of BLMV suspension were added to 50 pA of transport
medium containing 100 mrvi KHCO3 or K gluconate, 49 mM
TMA gluconate, 1 mi EGTA, 1 m Mg gluconate, 50 mM
mannitol, 50 mi HEPES, 1 mM 22Na gluconate, valinomycin,
pH 7.5. 22Na was measured by a rapid filtration technique
[21]. 22Na uptake was corrected for passive uptake by sub-
tracting the uptake in gluconate medium from the uptake in
bicarbonate medium.
Measurement of Na-dependent succinate transport in
BLMV
BLMV were equilibrated in a medium containing 100 mivi K
gluconate, 1 mi EGTA, I mM Mg gluconate, 100 mM mannitol,
50 mM HEPES, pH 7.5 (titrated with TMAOH). To study
transport, 10 p1 of vesicle suspension were added to 50 p1 of
transport medium containing 100 mrvi NaC1 or KC1, 1 mM
EGTA, I mivi Mg gluconate, 100 mivi mannitol, 50 mri HEPES,
pH 7.5 and 0.21 mivi [1,414C] succinic acid. Correction for
passive uptake was made by subtracting the uptake in KCI
medium from the uptake in NaCI medium.
Determination of transport kinetics
Kinetic analysis was carried out by utilizing the 3s 22Na
uptake as an index of the initial rate of each transporter as
described [23, 241. External Na concentration was varied by
replacing TMA gluconate with Na gluconate in the uptake
medium. Values for Km and Vmax were obtained by analyzing
Hanes-Woolf plots of the data ([NaJ/V vs. [Nat]) by the
method of least squares.
Effect of ET-1 antiserum on ET-1 stimulation of Na/H
exchange in BBMV and NatHCO3 cotransport in BLMV
Na/H exchange activity in BBMV and Na11HC03
cotransporter activity in BLMV were determined by measuring
22Na (1 mM) uptake at lOs in BBMV or BLMV that were
either untreated (control) or were subjected to one of the
following pretreatments for five minutes prior to transport
measurement: b_b M ET-l; ET-l antiserum (Peptide Interna-
tional, Louisville, Kentucky, USA) at 1:150 dilution; or ET-l
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Fig. 1. A. Effect of ET-1 on rabbit renal
cortical BBMV Na/H exchange activity.
22Na (1 mM) uptake was measured in
vesicles pretreated with 10—10 M ET-1 for five
minutes (•, •) or untreated controls (0, 0),
in absence (•, 0) or presence (•, 0) of 1 mM
amiloride. In the absence of amiloride, but not
in its presence, ET-1 pretreatment led to
significant stimulation of 22Na uptake at lOs,
20s, and 60s, indicating stimulation of the
amiloride-sensitive component of 22Na
uptake. B. Effect of ET-1 on rabbit renal
cortical BLMV Na/HCO3 cotransport
activity. 22Na (1 mM) uptake was measured
in vesicles pretreated with b_b M ET-1 for
five minutes (, •) or untreated controls (0,
0), in transport medium containing
bicarbonate (•, LI) or gluconate (•, 0). In
bicarbonate medium, but not in gluconate
medium, ET-1 pretreatment led to significant
stimulation of 22Na uptake at lOs, 20s, and
120 60s, indicating stimulation of Na/HCO3
mm cotransport activity. Results are expressed as
mean SEM (N = 3).
Table 1. Effect of ET-l dose and preincubation time on ET-l-stimulated 22Na uptake in rabbit renal cortical BBMV and BLMV
Preincubation time
mm
22Na uptake nmol/mg protein lOs
Control ET-l (1 x I0 M) ET-l (1X10°M) ET-1 (1 X 10 M)
5 15 5 15 5 15
BBMV 5.59 0.22 6.44 0.26" 6.14 0.30" 6.80 0.30" 6.53 0.41" 6.31 0.28" 6.06
(N = 3) (15 1%) (10 2%) (22 1%) (17 1%) (13 1%) (7 2%)
BLMV 2.25 0.10 2.79 0.11" 2.59 0.13" 2.90 o.Ila 2.77 016b 2.53 0.14" 2.38 0.08
(N = 4) (24 3%) (15 2%) (29 2%) (23 2%) (12 3%) (6 2%)
Values are means SEM. Values in parentheses represent percent increases as compared to control.
Values for BLMV represent HCO3-dependent 22Na uptake (the difference in 22Na uptake between bicarbonate and gluconate media).
Abbreviations are: ET-1, endothelin-l; BBMV, brush border membrane vesicles; BLMV, basolateral membrane vesicles.
"P < 0.005 vs. control
b P < 0.05 vs. control
and ET-1 antiserum combined (ingredients were premixed for
15 minutes prior to being added to vesicles).
Statistical analysis
Transport measurements in each individual experiment were
carried out in triplicate using fresh membrane preparations. For
each protocol, an N of 3 to 4 experiments was obtained. Data
represent means SEM. Statistical analysis of data utilized
paired 1-test for results obtained in the same vesicles and
one-way analysis of variance for comparison among groups.
Results
Figure 1A shows that Na/H exchange activity in BBMV
was significantly stimulated by 10 M ET-1. 22Na uptake in
the presence of an outward H gradient averaged 6.62 0.12
nmollmg protein in ET- 1 pretreated BBMV versus 5.49 0.22
nmol/mg protein in untreated controls at lOs (P < 0.001); 8.89
0.20 versus 7.70 0.17 at 20s (P < 0.001); 10,99 0.36 versus
9.71 0.28 at 60s (P < 0.01); and 2.64 0.13 versus 2.49 0.20
at 120 minutes (NS). When 22Na uptake was studied in the
presence of 1 m amiloride, a specific inhibitor of the Na/H
exchanger [25j, uptake values were markedly decreased and no
stimulation by ET- 1 was noted (Fig. 1A). Consequently, the
ET- 1 effect reflected stimulation of the amiloride-sensitive
component of 22Na uptake. 22Na uptake was not different
between ET-1 pretreated vesicles and controls at 120 minutes,
a time when pH and Na gradients are known to have dissi-
pated [261, indicating that the observeddifferences in transport
at earlier time points did not reflect differences in vesicle size.
In a dose-response analysis, the fractional increase in lOs 22Na
uptake as compared to control averaged 15 1% for i08 M
ET-1 (P < 0.005, N = 3); 22 1% for 10_b M (P < 0.05, N =
3); and 13 1% for 10" M (P < 0.05, N = 3; Table 1).
Preincubation of BBMV with ET-l (10, 10'°, or b0" M)for
15 minutes led to significant stimulation of 22Na uptake, albeit
consistently less than that following five minutes of pretreat-
ment (Table 1). Thus, ET-1 led to dose- and time-dependent
stimulation of Na/H exchange activity in BBMV.
Figure lB depicts the effect of 10_b M ET-1 on the time
course of 22Na uptake in BLMV. 22Na uptake in the pres-
ence of bicarbonate medium was markedly higher than that in
gluconate medium; ET- 1 stimulated 22Na uptake in a bicar-
bonate medium but had no effect in a gluconate medium. Thus,
HC03 -dependent 22Na uptake (the difference in 22Na up-
take between bicarbonate and gluconate media) averaged 2.79
0.07 nmol/mg protein in ET-1 pretreated BLMV versus 2.23
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Table 2. Effect of ET-1 antiserum on the stimulation of rabbit renal
cortical BBMV Na/H exchanger and BLMV Na/HCO3
cotransporter by ET-l
22Na uptake
nmol/mg protein lOs
BBMV BLMV
Control (N = 3) 5.43 0.18 2.22 0.13
ET-l (N = 3) 6.64 0.288 2.86 0.16k
ET-l antiserum (N = 3) 5.61 0.15 2.29 0.13
ET-l ÷ ET-l antiserum (N = 3) 5.77 0.22 2.47 0.14
Values are means SEM. Abbreviations are: ET-l, endothelin-1;
BBMV, brush border membrane vesicles; BLMV, basolateral mem-
brane vesicles
a P < 0.05 vs. control (one-way analysis of variance)
Table 3. Effect of ET-1 on the kinetic characteristics of rabbit renal
cortical Na/H exchanger and Na/HCO3cotransporter
Km 'max
mM nmol/mg protein - mm
Control ET- 1 Control ET- 1
BBMV Na/H4-
exchanger
BLMV Na/HCO3 7.5 0.5 7.4 0.4 184 9 234 ia
cotransporter
Values are means SEM. Abbreviations are: BBMV, brush border
membrane vesicles; BLMV, basolateral membrane vesicles; ET-1,
endothelin-1.
a P < 0.05 vs. control
8.0 0.2 7.9 0.1 638 10 764 128
0.06 in untreated controls at lOs (P < 0.005); 5.85 0.12
versus 4.78 0.09 at 20s (P <0.005); 8.59 0.22 versus 7.11
0.10 at 60s (P < 0.05); and 0.12 0.05 versus 0.15 0.04 at
120 minutes (NS). In a dose-response study, the fractional
increase in lOs 22Na uptake, as compared to control, averaged
24 3% for 10 MET-i (P <0.005, N 4); 29 2% for 10'°
M(P<0.005,N= 4);and 12 3%for 10_Il M(P<0.05,N=
4; Table 1). Similar to the BBMV studies, preincubation of
BLMV for 15 minutes with ET-1 (10_8 or i0'° M, though not
10_11 M) led to significant stimulation of lOs 22Na uptake,
which was less than that following five minutes of pretreatment
(Table 1). These results demonstrate that ET-l significantly
stimulated Na/HCO3 cotransport activity in BLMV in a
dose- and time-dependent fashion.
To probe the specificity of the observed effects, we examined
the influence of ET-1 on Nat-dependent D-glucose transport by
BBMV and Nat-dependent succinate transport by BLMV. In
BBMV, Na-dependent D-glucose uptake did not differ signif-
icantly between vesicles pretreated with 10 ET- 1 and their
untreated controls (Fig. 2A); similarly, pretreatment with 10_b
M ET-l had no effect on Na-dependent succinate transport by
BLMV (Fig. 2B). These results indicate that the stimulation of
the BBMV Na/H exchanger and the BLMV Na/HCO3
cotransporter by ET- 1 represents specific effects of the peptide.
In addition, we examined the effect of an ET-l antiserum on
the stimulation of the BBMV Na/H exchanger and the
BLMV Na/HCO3 cotransporter by ET-1. In the presence of
ET-1 antiserum, no significant stimulation of either transporter
by ET-1 was observed (Table 2). Furthermore, ET-i antiserum
alone had no effect on the activity of either transporter.
Kinetic analysis indicated that pretreatment with 10'° M
ET-1 significantly increased the Vmax of the BBMV Na/H
exchanger (764 12 vs. 638 10 nmollmg protein• mm; P <
0.05) but had no effect on the Km for Na (7.9 0.1 vs. 8.0
0.2 mM; NS; Table 3). Similarly, pretreatment with ET-l
significantly increased the Vmax of the BLMV Na7HCO3
cotransporter (234 0.6 vs. 184 9.1 nmollmg protein - mm (P
<0.05) but did not change the Km for Na (7.4 0.4 vs. 7.5
0.5 mM, NS).
Discussion
The results of the present study identify a heretofore unrec-
ognized mechanism for the modulation of proximal tubular
sodium reabsorption by ET- 1. Pretreatment of renal cortical
vesicles with physiologic concentrations of ET-1 elicited signif-
icant stimulation of the activities of the apical Na/H ex-
changer and the basolateral Na/HCO3 cotransporter. As
shown in Figure 1 and Table 1, preincubation of vesicles with10 ' M ET-l for five minutes enhanced the activity of each
transporter by approximately 25%. Such stimulation reflected a
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Fig. 2. A. Effect of ET-l on Na-dependent
D-glucose transport by rabbit renal cortical
BBMV. D-[3H} glucose (0.05 mM) uptake was
measured in vesicles pretreated with 10— M
ET-l for 5 minutes (•) or untreated controls
(0). No significant effect of ET-l was noted.
B. Effect of ET-1 on Na-dependent succinate
transport by rabbit renal cortical BLMV.
[1 ,4'4Cj succinic acid uptake was measured in
vesicles pretreated with l0b0 ET-1 for 5
minutes (•) or untreated controls (0). No
significant effect of ET-l was observed.
Results are expressed as mean SEM (N =
3).
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quantitatively comparable increase in the 'max of each trans-
porter but no change in the Km for sodium (Table 3). These
effects of ET-l were essentially abolished when an ET-l anti-
serum was also present in the incubation mixture (Table 2).
Moreover, the stimulation of the apical Na/H exchanger and
the basolateral Na4/HC03 cotransporter by ET-! displayed
specificity as judged from the failure of ET-l to alter the
activities of the apical Na-glucose transporter and the baso-
lateral Na-succinate transporter (Fig. 2). Thus, the present
data implicate ET-l as a novel, direct and specific modulator of
sodium reabsorption in the proximal tubule.
Stimulation of the apical Na/H exchanger and the basolat-
eral Na/HCO3 cotransporter by ET-l will enhance, of
course, the vectorial transport of sodium bicarbonate in the
proximal tubule. An additional consequence of increasing the
acidification of the proximal tubule is, however, the augmenta-
tion of sodium chloride reabsorption in this nephron segment
both via a direct transcellular mechanism (parallel Na/H and
Cl-base exchangers) and an indirect mechanism (elevated
luminal chloride concentration mediating a paracellular diffu-
sive flux) [271. Consequently, the effects of ET-l on the apical
Na/H exchanger and the basolateral Na/HCO3 cotrans-
porter herein described carry the potential of impacting both on
systemic acid-base balance and the regulation of extracellular
fluid volume.
Modulation of extracellular fluid volume by ET- 1 might
therefore emanate both from its vasoconstrictive effects on
renal hemodynamics and a direct effect on the proximal tubule.
Such modulation might encompass normal variations of sodium
intake as well as pathophysiologic states. Among the latter, of
particular interest is the case of hypertension: elevated levels of
ET- 1, whether circulating or local, might impact on the patho-
physiology of certain hypertensive disorders both by enhancing
systemic and renal vascular resistances and by promoting
proximal tubular sodium reabsorption. In this regard, the in-
creased proximal tubular sodium reabsorption characteristic of
some models of genetic hypertension in rats has been linked to
an overactive apical Na/H exchanger [28—3 1]. It is intriguing
to speculate that endothelin might be involved in the mediation
of such stimulation.
The profile of hemodynamic and direct proximal tubular
effects of ET- 1 suggested by our data nearly mirrors that of
angiotensin II, a potent mediator of systemic hypertension [15].
Increase in the absolute proximal tubular sodium reabsorption
by angiotensin II that is effected by the apical Na/H ex-
changer and the basolateral Na/HCO3 cotransporter has
been clearly established in studies utilizing micropuncture,
perfused tubules and membrane vesicles [15, 32—35]. As such,
angiotensin II has been suggested to be an important mediator
of glomerular tubular balance and tubular glomerular feedback,
mechanisms that are key factors in the maintenance of extra-
cellular fluid volume [15]. Our observations raise the possibility
of a role for ET- 1 in the regulation of these phenomena.
Studies on the effects of exogenous ET- 1 on sodium handling
in the intact kidney have yielded conflicting results reporting
natriuresis [13, 36] and antinatriuresis [37, 381. However, such
studies offer little insight into the direct tubular effects of ET- 1
on sodium reabsorption due to the confounding influence of a
number of other factors. Thus, the supraphysiologic doses of
ET-1 employed in these studies result in substantial changes in
systemic and renal hemodynamics, thereby impacting on renal
perfusion pressure, glomerular ifitration rate and, likely, pert-
tubular physical factors—all determinants of renal sodium
handling. In addition, ET-1 alters levels of an array of other
sodium-regulating substances including atrial natriuretic pep-
tide, prostanoids, renin-angiotensin-aldosterone axis, and cate-
cholamines [2, 3, 36—39]. It is of interest, however, that a recent
study employing low-dose ET-1 infusion that only doubled the
normal circulating ET-l levels, demonstrated an antinatriuretic
effect when compared with vehicle infusion [40]. Moreover,
infusion of an ET-1 antiserum in sodium-restricted rats led to
natriuresis in the absence of changes in whole kidney or
systemic hemodynamics [201. In this same study, ET-1 antise-
rum had no effects in sodium-replete rats, thereby suggesting a
role for the ET- 1 system in fostering antinatriuresis during
sodium restriction. Indeed, several factors which are known to
be elevated in sodium depletion, such as angiotensin II or
catecholamines, also enhance ET-l expression in cultured
endothelial cells [1, 41].
Recent studies of isolated perfused rat straight proximal
tubules reported a decrease in fluid and HC03-reabsorption
rates by addition of ET-1 (10—u M) in the bath [42]. The cause of
the discrepancy between those results and our findings remains
unclear, although it might be accounted for by methodologic or
species differences. In full accord with our findings, however,
preliminary observations by Guntupalli, Phelps and DuBose
[43] described marked stimulation of the Na/H exchanger by
ET-l (l0— to 10_Il M) in BBMV isolated from rat proximal
tubule slices. We do recognize the generic drawback of mem-
brane vesicle studies that stems from the potential contamina-
tion by extraneous tissues. To the extent that such contamina-
tion is substantial and the involved tissues bear ET-1-sensitive
transporters, the conclusions of our studies might be affected.
Notwithstanding, extensive work utilizing a variety of experi-
mental approaches will be needed to sort out the influence of
ET- 1 on the various determinants of renal sodium handling and
its impact on the modulation of extracellular fluid volume in
health and disease. Such analysis will require the development
of effective ET-l biosynthesis blockers or receptor antagonists.
Several lines of evidence suggest that, in addition to being a
target organ of ET-1, the kidney might be an important source
of this peptide. indeed, ET-1 production and release have been
demonstrated in glomerular endothelial cells [44], mesangial
cells [45], and a variety of renal epithelial cell lines (MDCK,
LLC-PK1) [46, 47]. Thus, circulating ET-l or glomerular cell-
derived ET-1 might gain access to the brush border and
basolateral membranes through the filtrate or the peritubular
circulation. In this regard, endothelin-like immunoreactivity
has recently been identified in brush border membranes from
early proximal tubular segments of rats [18]. Whether native
proximal tubular cells produce ET-1 has not been established,
however. Nonetheless, the present data coupled with the ob-
servation of local endothelin-like immunoreactivity suggest that
the proximal tubular epithelium might be an effector cell for
ET-l. In support of this contention, autoradiographs of 1251..
labeled ET-l demonstrate binding in rat proximal tubules, albeit
of lesser degree than in the glomerulus and the inner medulla
[19]. So far, however, ET-l receptors have not been described
in proximal tubular cells, although such have been identified
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and characterized in mesangial cells and inner medullary col-
lecting duct cells [48, 49].
In vascular smooth muscle cells [50], cardiac myocytes [51]
and glomerular mesangial cells [521, ET-l stimulates Na/H
exchange via a protein kinase C-mediated pathway resulting in
intracellular alkalinization. By contrast, the effects of ET- I on
the proximal tubular apical Na/H exchanger and the baso-
lateral Na/HCO3 cotransporter identified in our vesicle stud-
ies must reflect mechanisms independent of intracellular
events. Indeed, both intracellular and membrane-related mech-
anisms have been described for the effects of angiotensin II on
proximal tubular sodium transport. Intracellular events in-
volved in the angiotensin 11-induced stimulation of the brush
border membrane Na/H exchanger include G protein-medi-
ated reduction in adenylate cyclase activity and an increase in
phospholipase C activity [15]. In addition, in brush border
membrane vesicles, angiotensin II directly stimulates amilo-
ride-sensitive Na uptake, an effect that has been related to an
increase in phospholipase A2 activity [32, 35]. In this regard,
ET- 1 is known to stimulate phospholipase A2 activity in vascu-
lar smooth muscle [53]. Whether the in vivo response to ET-I in
the proximal tubule is mediated by both intracellular and
membrane-related events remains to be defined.
In summary, our data identify a direct and specific effect of
ET- 1 to stimulate the apical Nat/H + exchanger and the baso-
lateral Na/HCO3 cotransporter, the major pathways for the
vectorial transport of sodium in the proximal tubule. This effect
might have important implications for volume homeostasis
under physiologic and pathophysiologic circumstances, includ-
ing hypertensive disorders.
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